Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

JWH 098

  • Zoom
    JWH 098
  • JWH 098
Cat No: 10680
Biochemicals - Drugs Of Abuse
Cayman
€46.00
Price is excluding VAT and does not include packaging neither shipping

JWH 098 is a potent synthetic cannabinoid (CB), activating the CB1 receptor with a Ki value of 4.5 nM and the CB2 receptor with a Ki value of 1.88 nM.{16797} Its effects in cells and animals are unknown.

More

This product can only be bought through Cayman Chemical. Please contact us.

- +
Territorial Availability: Available through Bertin Pharma only in Europe
Synonyms:
  • (4-methoxy-1-naphthalenyl)(2-methyl-1-pentyl-1H-indol-3-yl)-methanone
Correlated keywords:
  • JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles analytical references standards
Product Overview:
JWH 098 is a potent synthetic cannabinoid (CB), activating the CB1 receptor with a Ki value of 4.5 nM and the CB2 receptor with a Ki value of 1.88 nM.{16797} Its effects in cells and animals are unknown.
Size 1 mg
Shipping dry ice
Stability Store at -20 degrees; shelf life 730 days
CAS Number 316189-74-9
Molecular Formula C26H27NO2
SMILES CCCCCN1C(C)=C(C(C2=C(C=CC=C3)C3=C(OC)C=C2)=O)C4=C1C=CC=C4
Molecular Weight 385,5
Formulation A crystalline solid
Purity ≥98%
Custom Code 2933.49
UNSPSC code 12352100

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : JWH 098 There are 10 products.

Search